Dialysis-Related Amyloidosis Treatment Act of 2020
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Dialysis-Related Amyloidosis Treatment Act of 2020
This bill provides for Medicare coverage and payment of treatments for dialysis-related amyloidosis (a complication of kidney failure that can occur as a result of long-term dialysis).
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8652: Dialysis-Related Amyloidosis Treatment Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-8652/
"H.R. 8652: Dialysis-Related Amyloidosis Treatment Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-8652/.
H.R. 8652, 116th Cong. (2026), https://openamerica.io/bill/116-HR-8652/.
[H.R. 8652: Dialysis-Related Amyloidosis Treatment Act of 2020](https://openamerica.io/bill/116-HR-8652/)